Toll Free: 1.855.428.7322

Debate over Morsellation

Debate over Morsellation


What is the Risk?

Since the FDA warning in April, Johnson & Johnson has removed the power morcellator from the market. In addition, many hospitals placed moratoriums on the use of the device.

While some professionals may argue over the extent of the risk, it is fair to say that there is not any risk at all. The FDA believes that 1 in 350 women undergoing hysterectomy or myomectomy for the treatment of fibroids are found to have an unsuspected uterine sarcoma.

The FDA has acknowledged the evidence that morcellation spreads hidden cancer is limited. But the agency says there is consistency across small studies showing a worsened prognosis when hidden cancers are cut up inside the body.

Still, some gynecologists continue to employ morcellators to remove common benign uterine growths known as fibroids.

Patients need to be informed of the risk of spreading unsuspected uterine sarcoma when undergoing this procedure.

Latest Posts

Morcellator Trial Lawyers

Our experienced morcellator trial lawyers are accepting cases nationwide.

Social Media

eMail Us

Attorney Advertising